----------------------------------
UNITED STATES OMB APPROVAL
SECURITIES AND EXCHANGE COMMISSION ----------------------------------
Washington, D.C. 20549 OMB Number: 3235-0058
FORM 12b-25 Expires: March 31, 2006
NOTIFICATION OF LATE FILING Estimated average burden hours per
response.....................2.50
----------------------------------
SEC FILE NUMBER
----------------------------------
CUSIP NUMBER
----------------------------------
(Check one): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR
For Period Ended: December 31, 2005
-------------------------------------------------------------------------------------------------
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:
-----------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
Read Instructions (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
--------------------------------------------------------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
--------------------------------------------------------------------------------------------------------------------------------
PART I -- REGISTRANT INFORMATION
VISUALMED CLINICAL SOLUTIONS CORP.
--------------------------------------------------------------------------------
Full Name of Registrant
ANCONA MINING CORP.
--------------------------------------------------------------------------------
Former Name if Applicable
1035 LAURIER ST. WEST, SUITE 200
--------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)
MONTREAL, QUEBEC CANADA H2V 2L1
--------------------------------------------------------------------------------
City, State and Zip Code
PART II -- RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
(a) The reason described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or
expense
(b) The subject annual report, semi-annual report, transition report
on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or
[X] portion thereof, will be filed on or before the fifteenth
calendar day following the prescribed due date; or the subject
quarterly report or transition report on Form 10-Q, or subject
distribution report on Form 10-D, or portion thereof, will be
filed on or before the fifth calendar day following the
prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
PART III -- NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q,
10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be
filed within the prescribed time period.
VisualMED Clinical Solutions Corp. (the "Company") hereby requests an
extension of time to file its Quarterly Report on Form 10-QSB for the period
ended December 31, 2005. The Company was unable to file its Form 10-QSB by
February 14, 2006 without unreasonable effort or expense. The Company is a
development stage company and has limited resources. Much of the Company's
human resources has been expended to ensure that the Form 10-QSB for the
period ended December 31, 2005 also responses to the comments of the Staff
of the Securities and Exchange Commission regarding the Company's Form 10-KSB
for the fiscal year ended June 30, 2005 and Form 10-QSB for the period ended
September 30, 2005 which the Company is currently responding to. In addition,
the Company's Chief Financial Officer was recently injured and hospitalized,
causing further delay in the Company's filings. The Company currently
anticipates that the Form 10-QSB will be filed by no later than the second
calendar day following the date on which the Form 10-QSB was due.
SEC 1344 (03-05) Persons who are to respond to the collection of information
contained in this form are not required to respond unless
the form displays a currently valid OMB control number.
Page 1 of 2
(Attach extra Sheets if Needed)
PART IV -- OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
JAYNE H. KIRBY 514 274-1115
--------------------------------- -------------- -------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If answer is no,
identify report(s).
[X] Yes [ ] No
---------------------------------------------------------------------------
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion
thereof?
[ ] Yes [X] No
---------------------------------------------------------------------------
If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
--------------------------------------------------------------------------------
VISUALMED CLINICAL SOLUTIONS CORP.
--------------------------------------------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date FEBRUARY 15, 2006 By /s/ GERARD DAB
---------------------------- ------------------------------------
ATTENTION
--------------------------------------------------------------------------------
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).
--------------------------------------------------------------------------------
GENERAL INSTRUCTIONS
1. This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General
Rules and Regulations under the Securities Exchange Act of 1934.
2. One signed original and four conformed copies of this form and amendments
thereto must be completed and filed with the Securities and Exchange
Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the
General Rules and Regulations under the Act. The information contained in
or filed with the form will be made a matter of public record in the
Commission files.
3. A manually signed copy of the form and amendments thereto shall be filed
with each national securities exchange on which any class of securities of
the registrant is registered.
4. Amendments to the notifications must also be filed on Form 12b-25 but need
not restate information that has been correctly furnished. The form shall
be clearly identified as an amended notification.
5. Electronic Filers: This form shall not be used by electronic filers unable
to timely file a report solely due to electronic difficulties. Filers
unable to submit reports within the time period prescribed due to
difficulties in electronic filing should comply with either Rule 201 or
Rule 202 of Regulation S-T ('SS'232.201 or 'SS'232.202 of this chapter) or
apply for an adjustment in filing date pursuant to Rule 13(b) of Regulation
S-T ('SS'232.13(b) of this chapter).
Page 2 of 2
STATEMENT OF DIFFERENCES
------------------------
The section symbol shall be expressed as ................................ 'SS'